Study of Protein Translocation in Patients With Beta-Oxidation Disorders
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00004348|
Recruitment Status : Unknown
Verified January 2000 by Office of Rare Diseases (ORD).
Recruitment status was: Active, not recruiting
First Posted : October 19, 1999
Last Update Posted : June 24, 2005
I. Characterize inheritance patterns of mutations in patients with beta-oxidation disorders.
|Condition or disease|
|Beta-Oxidation Disorder Peroxisomal Disorders|
Patients undergo clinical and molecular analysis of beta-oxidation enzyme metabolism. The evaluation includes a urinary metabolite profile, and DNA and familial studies.
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Study Start Date :||September 1995|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00004348
|Study Chair:||Arnold W. Strauss||Washington University School of Medicine|